Interesting article in the SMH today about a biotech considering moving to UK or US due to higher ratings.
Like Resmed, SRX gets the significant % of it's sales in the US (and will do so over the next few years - IMO) and at some point a duel listing may be beneficial.
PE ratios for biotechs in the US are far higher than Aus - now that would be interesting. Please :-)
- Forums
- ASX - By Stock
- SRX
- ubs upgrade to buy
ubs upgrade to buy, page-11
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M |
Open | High | Low | Value | Volume |
17.5¢ | 17.5¢ | 17.3¢ | $569.2K | 3.252M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1266574 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 1608936 | 39 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1266574 | 0.175 |
5 | 1596422 | 0.170 |
1 | 18186 | 0.165 |
1 | 11500 | 0.145 |
1 | 2577 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 1608936 | 39 |
0.185 | 49428 | 5 |
0.190 | 198822 | 8 |
0.195 | 28179 | 3 |
0.200 | 527416 | 8 |
Last trade - 14.31pm 26/08/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |